Pulsenmore wins FDA nod for home ultrasound pregnancy device

Pulsenmore wins FDA nod for home ultrasound pregnancy device

This is the first time such approval has been received for a home ultrasound device.

Pulsenmore stock up as at-home ultrasound secures FDA de novo authorisation

Pulsenmore’s at-home ultrasound platform, Pulsenmore ES, has received de novo authorisation from the US Food and Drug Administration (FDA).The post Pulsenmore stock up as at-home ultrasound secures FDA de novo authorisation appeared first on Medical Device Network.

FDA Grants De Novo Approval for Home Use of Prenatal Ultrasound Platform

Already in use in multiple countries, the Pulsenmore ES ultrasound platform reportedly enables expectant mothers to transmit ultrasound video clips through a smartphone app for remote interpretation.